Work Together for Win-win Cooperation

----Conference for Antibody Commercial Production

1.Purpose of the conference

China's antibody industry has developed explosively in recent years. With the approval of several biosimilar for marketing, China's antibody industry has experienced a period of technological accumulation and has entered the stage of commercial production. At the same time, with the continuous expansion of the scope of domestic centralized procurement and the strengthened competition of foreign primary antibodies, how to improve the output and reduce the cost of domestic antibody commercial production on the premise of ensuring the quality has become a prominent problem.

The national "14th Five-Year Plan" for the development of the pharmaceutical industry emphasizes the importance of the upstream supply chain of medicine and repeatedly mentions the "stable and controllable supply chain", including equipment and equipment, culture medium development and industrialized production, industrial upstream and downstream consumables and starting packaging materials, and other subdivisions. From this, we can see that China's antibody drug industry is facing rare opportunities and great challenges!

If you are still confused about how to increase production and reduce costs;

If you are eager to visit the production line in person, compare the differences between imported reactors and domestic reactors, as well as domestic and foreign purification equipment, and further grasp the capabilities of domestic large reactors and domestic purification equipment;

If you want to know the difference between Chinese and foreign industrialized culture media and the current market situation of industrial grade consumables;

If you want to master the current development of China's CDMO market first;

Then you must not miss this conference!

2.Conference information

Time: according to the domestic epidemic situation, the meeting time is expected to be from July to August;

Venue: Hualan Biologic Industrial Park, xinxiang Plain Demonstration Area, Henan Province

Sponsor: Henan Shengming Biotechnology Research Institute Co., Ltd

Co-organizers (in no particular order):

Shanghai Tofflon Science and Technology Co., Ltd

Lisure Science (Suzhou) Co., Ltd

Shanghai OPM Biosciences Co., Ltd

Strategic partners (in no particular order):

Shanghai LePure Biotech Co., Ltd

Hangzhou Cobetter Filter Equipment Co., Ltd

Bestchrom (Shanghai) Biosciences Co., Ltd

Chengdu Shenke Industrial Equipment Installation Co., Ltd

Participation method: participating units and partners can publicize the meeting with official account and register in the form of appointment registration. The organizer will send an invitation letter after screening customers according to the registration.

Henan Shengming Biotechnology Co., Ltd. (hereinafter referred to as Shengming Bio) is an emerging CDMO company. On the occasion of the completion of its 6 × 5000L antibody production line, users and suppliers in the industry are sincerely invited to discuss and visit the Shengming biological production site on "Seminar on How to Break Through the Barriers of Antibody Commercial Production", discuss the development of the biomedical industry, build a collaborative development mechanism, form a complete industrial ecosystem, and promote the high-quality development of the domestic antibody industry.

3.Activity arrangement

The first day:

15: 00-18:00 Registration place: Xinxiang Big Data Industrial Park

18: 30-20:00 Dinner and accommodation: Xinxiang Big Data Industrial Park

The second day:

7: 50-8:30 Drive to Hualan Biologic Industrial Park

8: 45-9:30 Guest speech: Guest chair: McAb Development under the New Situation

9: 30-10:00 Shengming Bio: Monoclonal Antibody R & D and Industry

10: 00-10:30 Tofflon Technology Topic

10: 30-10:50 Lisure Technology Topic

10: 50-11:10 OPM Biology Topic

11: 10-12:10 visit Shengming Bio large-scale production line

12: 10-13:00 Buffet lunch

13: 00-15:00 Guests speak, subject to be determined